Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06114316
Other study ID # ayakdasdagli
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 10, 2018
Est. completion date July 10, 2019

Study information

Verified date October 2023
Source Izmir Katip Celebi University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Abstract Aim: This study aimed to determine the effect of individualized nursing interventions based on the Roy Adaptation Model on the recovery of alcohol addicts. Method: This was an experimental study with pretest-posttest, follow-up, and a control group. It included 64 individuals who completed their detoxification process and met the inclusion criteria. The experimental group was provided with individualized care, and interventions were made in line with the Roy Adaptation Model. The personal behaviors that could be related to recurrence (physiological, self-concept, role function, and mutual commitment) and the stimuli that caused recurrence (focal and affecting) were assessed, objectives were determined, and nursing interventions were carried out in line with these objectives. The interventions planned for diagnosing ineffective coping were selected according to the patients' needs among the "support coping" interventions under the title of the behavioral area in the Nursing Intervention Classification (NIC). The data were collected using an introductory information form, the Recovery Assessment Scale (RAS), the Turkish Version of the World Health Organization Quality of Life Instrument (WHOQOL-BREF-TR), and the Penn Alcohol Craving Scale (PACS).


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date July 10, 2019
Est. primary completion date March 10, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: Diagnosed with alcohol use disorder according to DSM 5 Completed the detoxification phase were able to understand the scales and forms and maintain individual interviews were between 30 and 60 years of age Exclusion Criteria: - with a psychotic disorder

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
individualized nursing interventions based on the Roy Adaptation Model /experimental
The personal behaviors that could be related to recurrence (physiological, self-concept, role function, and mutual commitment) and the stimuli that caused recurrence (focal and affecting) were assessed, objectives were determined, and nursing interventions were carried out in line with these objectives. The interventions planned for diagnosing ineffective coping were selected according to the patients' needs among the "support coping" interventions under the title of the behavioral area in the Nursing Intervention Classification (NIC). A total of 10 individual interviews were made twice a week for about 45 to 60 minutes. The interviews were evaluated by determining the area specific Nursing outcome classification (NOC) (self respect, social support, mood management, role performance).

Locations

Country Name City State
Turkey Izmir Katip Çelebi University Ataturk Training and Research Hospital Izmir Karabaglar

Sponsors (1)

Lead Sponsor Collaborator
Izmir Katip Celebi University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Recovery Assessment Scale (RAS) The RAS was developed by Corrigan et al. (2004) and tested for validity and reliability in Turkish by Güler and Gürkan (2017). The scale consisted of 24 questions under 5 subscales. It was a five-point Likert type scale scored as follows: 1 = Strongly Disagree; 2 = Disagree; 3 = Not Sure; 4 = Agree; and 5 = Strongly Agree. The titles of the subscales were self-confidence and hope, seeking help, orientation to objectives and success, trust in the environment, and coping with the symptoms. Assessment could be made by scoring each item individually or over the total score. High total scores indicated high recovery. Cronbach's alpha coefficient of the Turkish form of the scale was 0.90. A pretest was administered before starting the study and a posttest was administered 1 month later.
Primary World Health Organization Quality of Life Instrument This health-related quality of life scale was developed by the World Health Organization and tested for validity and reliability in Turkish by Eser et al. The scale consisted of 27 questions that assessed individuals' physical, mental, social, and environmental well-being. Since each area independently represented the quality of life in its own domain, the area scores were calculated as between 4 and 20. High scores indicated a higher quality of life . The scale was selected by the substance addiction institute as the best scale that assessed the recovery of substance addiction. Cronbach's alpha coefficients of the subscales ranged between 0.73 and 0.84. A pretest was administered before starting the study and a posttest was administered 1 month later.
Primary Penn Alcohol Craving Scale This was a five-item question form developed by Flannery et al. (1999) to assess the wish to drink alcohol (frequency, intensity, duration, resistance, and general craving). Each item was scored between 0 and 6. Thus, the maximum total severe craving score was 30. The scale was tested for validity and reliability in Turkish by Evren et al. (2008) with alcohol addicts, and its Cronbach alpha coefficient was found to be 0.94. A pretest was administered before starting the study and a posttest was administered after the study was completed. Follow-up testing was performed 1 month and 3 months after the end of the study.
See also
  Status Clinical Trial Phase
Recruiting NCT04876443 - Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)
Recruiting NCT05042180 - Virtual Reality-Assisted Cognitive Behavioral Therapy for Alcohol Dependence (CRAVR) Phase 2
Recruiting NCT04599270 - Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) of Vulnerable Teenagers N/A
Recruiting NCT05361603 - Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Recruiting NCT04990765 - Virtual Reality-Assisted Cognitive Behavioral Therapy for Alcohol Dependence (CRAVR-Pilot) Phase 2
Recruiting NCT05730504 - Evaluating the Effectiveness of Mobile Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder N/A
Recruiting NCT05434416 - The Efficacy of a Mobile Application in Reducing Craving and Lapse Risk in Alcohol and Stimulants Problematic Use N/A
Not yet recruiting NCT05134675 - Does Homebrewing Beer Affect Urinary Tract Symptoms and Bladder Cancer
Recruiting NCT05322226 - Addiction Intervention in Liver Transplantation Candidates N/A
Terminated NCT04881500 - Impact of a Brief Motivational Intervention Including Counter-marketing Arguments With a Population of Patients With Moderate to Severe Alcohol Use Disorders Who Are Followed up on an Outpatient Basis (Primary Care or Addictology) (DEPREV_Phase 3) N/A
Recruiting NCT05490589 - Evaluation of the Implementation of a Parenting Program in Parents With Children Aged 4 to 12 Years and One Parent With an Alcohol Use Disorders N/A
Recruiting NCT06105853 - Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder N/A
Completed NCT03232112 - Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence? Phase 2
Active, not recruiting NCT04927455 - Pilot Study to Evaluate "Intégrer et Accompagner Les Consommations d'Alcool!" (IACA!)'s Impact and Transferability